Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Enochian Biosciences Inc (ENOB)

Enochian Biosciences Inc (ENOB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Enochian Biosciences Inc 1927 Paseo Rancho Castillo Los Angeles CA 90032 USA

www.enochianbio.com P: 305-918-1980

Description:

Enochian BioSciences Inc. engages in the research and development, manufacturing and clinical trials of pharmaceutical and biological products for the human treatment of HIV and cancer. The company's product pipeline consists of ENO-1001, ENO-2001, ENO-3001, ENO-1002, ENO-5001 and ENO-4001. Enochian BioSciences Inc. is based in Los Angeles, United States.

Key Statistics

Overview:

Market Capitalization, $K 40,799
Enterprise Value, $K 36,209
Shares Outstanding, K 58,284
Annual Sales, $ 0 K
Annual Net Income, $ -113,430 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,330 K
60-Month Beta 1.09
% of Insider Shareholders 21.72%
% of Institutional Shareholders 7.16%
Float, K 45,625
% Float 78.28%
Short Volume Ratio 0.17

Growth:

1-Year Return -75.00%
3-Year Return -84.62%
5-Year Return -82.54%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 05/12/23
Next Earnings Date 08/11/23
Earnings Per Share ttm -0.08
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 33.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ENOB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -154.69%
Return-on-Assets % -130.66%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.59
Book Value/Share 1.19
Interest Coverage -305.57
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar